STRATA Enterprise Value Over E B I T D A from 2010 to 2025

SSKN Stock  USD 2.72  0.15  5.84%   
STRATA Skin Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -7.84. During the period from 2010 to 2025, STRATA Skin Enterprise Value Over EBITDA quarterly data regression pattern had range of 344 and standard deviation of  80.88. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(7.47)
Current Value
(7.84)
Quarterly Volatility
80.87677128
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 47.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 1.43. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.
  
Check out the analysis of STRATA Skin Correlation against competitors.

Latest STRATA Skin's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of STRATA Skin Sciences over the last few years. It is STRATA Skin's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STRATA Skin's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Very volatile
   Enterprise Value Over E B I T D A   
       Timeline  

STRATA Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(21.13)
Coefficient Of Variation(382.72)
Mean Deviation44.78
Median(1.03)
Standard Deviation80.88
Sample Variance6,541
Range344
R-Value0.05
Mean Square Error6,992
R-Squared0
Significance0.86
Slope0.82
Total Sum of Squares98,116

STRATA Enterprise Value Over E B I T D A History

2025 -7.84
2024 -7.47
2023 -8.3
2022 26.98
2021 26.23
2020 -307.23
2019 37.03

About STRATA Skin Financial Statements

STRATA Skin investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how STRATA Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(7.47)(7.84)
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out the analysis of STRATA Skin Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
8.978
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.09)
Return On Equity
(0.73)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.